PERCEPTIVE ADVISORS LLC
Q2 2022 13F-HR Holdings
Net value change ($000)
-1,799,470
(-36.0%)
New positions
9
Sold out positions
30
Turnover %
26.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AMLX | 49,246 | 260.0% |
| Seagen Inc. | 39,635 | NEW |
| LYRA | 38,724 | 298.9% |
| LLY | 32,423 | NEW |
| FOLD | 27,904 | 10.7% |
| ACLX | 20,647 | NEW |
| HRMY | 20,084 | NEW |
| VERU | 18,482 | 87.7% |
| BMRN | 14,917 | NEW |
| HilleVax, Inc. | 8,360 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| AGILE THERAPEUTICS INC | -178,447 | -100.0% |
| SpringWorks Therapeutics, Inc. | -160,343 | -62.7% |
| Horizon Therapeutics Public Ltd Co | -142,864 | -100.0% |
| LIANY | -86,777 | -41.5% |
| IOVA | -72,588 | -35.7% |
| OM | -70,665 | -82.6% |
| IVERIC bio, Inc. | -67,858 | -77.2% |
| APLS | -60,756 | -80.7% |
| CCCC | -44,749 | -88.6% |
| Prometheus Biosciences, Inc. | -44,666 | -48.5% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
10,239
(0.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|